Fund HoldingsVR Adviser, LLC

Total Portfolio Value
$1.18B
Total Bought
$176.74M
Total Sold
$114.07M
Net Transaction
+$62.68M
Filing Period:
Securities
SharesValue ($K)
Q4 2024
Q1 2025
Change
Q4 2024
Q1 2025
Weight (%)
Change
METSERA INC03,750,662+3,750,6620102,0938.69%+102,093
KALVISTA PHARMACEUTICALS INC6,249,7316,703,985+454,25452,93577,3646.58%+24,429
SOLID BIOSCIENCES INC02,481,400+2,481,40009,1810.78%+9,181
SAVARA INC(SVRA)03,257,639+3,257,63909,0240.77%+9,024
SURROZEN INC0632,931+632,93107,3800.63%+7,380
CIDARA THERAPEUTICS INC765,7231,051,518+285,79520,58322,6501.93%+2,067
ZURA BIO LTD2,023,1665,023,166+3,000,0005,0586,4800.55%+1,422
PERCEPTIVE CAP SOLUTIONS COR
CL A ORD SHS
750,000750,00007,6357,7250.66%+90
TENAX THERAPEUTICS INC208,333208,33301,2901,3650.12%+75
INSTIL BIO INC33,17733,17706335760.05%-57
GLYCOMIMETICS INC3,000,0003,000,00007476300.05%-117
CASI PHARMACEUTICALS INC987,259987,25902,7942,1320.18%-661
TENAYA THERAPEUTICS INC1,555,5561,555,55602,2248870.08%-1,338
TREVI THERAPEUTICS INC(TRVI)1,266,457615,506-650,9515,2183,8720.33%-1,346
ABIVAX SA(ABVX)1,345,7801,345,78009,8518,4110.72%-1,440
CENTURY THERAPEUTICS INC3,957,1862,498,069-1,459,1173,9971,1890.10%-2,808
TAYSHA GENE THERAPIES INC(TSHA)3,225,1800-3,225,1805,5800-5,580
APPLIED THERAPEUTICS INC9,990,5915,567,709-4,422,8828,5542,7220.23%-5,832
TERNS PHARMACEUTICALS INC1,077,0900-1,077,0905,9670-5,967
CULLINAN THERAPEUTICS INC(CGEM)1,379,9651,379,965016,80810,4460.89%-6,362
DIANTHUS THERAPEUTICS INC(DNTH)1,744,3731,744,373038,02731,6432.69%-6,384
ASTRIA THERAPEUTICS INC2,457,3482,457,348021,96913,1221.12%-8,846
AQUESTIVE THERAPEUTICS INC2,629,7860-2,629,7869,3620-9,362
COGENT BIOSCIENCES INC(COGT)5,684,4115,684,411044,33834,0502.90%-10,289
ENGENE HOLDINGS INC
COM
5,046,4145,046,414033,55922,6081.92%-10,951
ENLIVEN THERAPEUTICS INC4,026,3314,026,331090,59279,2386.74%-11,354
ARTIVA BIOTHERAPEUTICS INC1,609,5691,609,569016,2244,8290.41%-11,396
PHARVARIS N V
COM
3,220,1303,112,720-107,41061,73048,8704.16%-12,860
MERSANA THERAPEUTICS INC10,257,7903,574,325-6,683,46514,6691,2300.10%-13,438
4D MOLECULAR THERAPEUTICS IN2,952,371677,600-2,274,77116,4452,1890.19%-14,256
OCULAR THERAPEUTIX INC(OCUL)12,762,46212,762,4620108,99193,5497.96%-15,443
ORIC PHARMACEUTICALS INC(ORIC)4,394,5273,182,527-1,212,00035,46417,7591.51%-17,705
ERASCA INC(ERAS)16,216,21616,216,216040,70322,2161.89%-18,486
SPYRE THERAPEUTICS INC(SYRE)2,685,4482,685,448062,51743,3303.69%-19,188
ORUKA THERAPEUTICS INC(ORKA)3,285,6204,148,428+862,80863,70842,5633.62%-21,145
VIRIDIAN THERAPEUTICS INC(VRDN)3,882,7093,882,709074,43252,3394.45%-22,093
UPSTREAM BIO INC2,295,3192,295,319037,73514,0471.20%-23,688
MERUS N V592,4110-592,41124,9110-24,911
DYNE THERAPEUTICS INC(DYN)2,173,9132,173,913051,21722,7391.93%-28,478
PRAXIS PRECISION MEDICINES I(PRAX)989,985989,985076,18937,4913.19%-38,699
APOGEE THERAPEUTICS INC(APGE)8,493,3218,493,3210384,747317,31027.00%-67,437
Page 1 of 1